Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | GLA | P06280 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 2/20 | 0.50 |
| ▸ | CASP7 | P55210 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | NQO2 | P16083 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Naphthalene SCHEMBL27472463 | 0.96 | KDM4E (0.46) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL6896388 | 0.82 | KDM4E (0.52) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL7915229 | 0.76 | TLR7 (0.34) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL27550242 | 0.76 | PDE10A (0.55) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL641899 | 0.76 | PDE10A (0.66) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL1478795 | 0.76 | MEN1 (0.61) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL29377848 | 0.76 | PDE10A (0.66) | KDM4EALDH1A1GLAHPGDMAOA | |
| SCHEMBL7756511 | 0.76 | KDM4E (0.48) | KDM4EALDH1A1GLAHPGDMAOA | |
| Iodide SCHEMBL8029601 | 0.74 | PDE10A (0.63) | KDM4EALDH1A1GLAHPGDMAOA | |
| Hydrochloric Acid SCHEMBL1603404 | 0.74 | PDE10A (0.63) | KDM4EALDH1A1GLAHPGDCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104761584-A | Acridinium ester derivative, synthesis method and application thereof | BEIJING LEADMAN BIOCHEMISTRY CO LTD | 2015-07-08 | — | — | CN | claimed |
| CN-104761584-A | Acridinium ester derivative, synthesis method and application thereof | BEIJING LEADMAN BIOCHEMISTRY CO LTD | 2015-07-08 | — | — | CN | disclosed |
| EP-1054933-B1 | CHEMILUMINESCENT REACTIONS USING DIHYDROXYAROMATIC COMPOUNDS AND HETEROCYCLIC ENOL PHOSPHATES | LUMIGEN INC (US) | 2006-09-06 | — | — | EP | disclosed |
| CN-1173954-C | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | 3 | 2004-11-03 | — | — | CN | disclosed |
| US-6635437-B2 | Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs | LUMIGEN, INC. | 2003-10-21 | — | — | US | disclosed |
| EP-1054933-A4 | CHEMILUMINESCENT REACTIONS USING DIHYDROXYAROMATIC COMPOUNDS AND HETEROCYCLIC ENOL PHOSPHATES | LUMIGEN INC (US) | 2003-07-09 | — | — | EP | disclosed |
| EP-0819119-B1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030023089-A1 | Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes | AKHAVAN-TAFTI HASHEM (US) | 2003-01-30 | — | — | US | disclosed |
| US-6296787-B1 | ACRIDINE AND PHENANTHRIDINE ALKENYL PHOSPHATE DERIVATIVES | LUMIGEN, INC. | 2001-10-02 | — | — | US | disclosed |
| CN-1312252-A | Intermediate of chemical compound generating chemical illumination when reacts with phosphatase | RUMIGEN CO (US) | 2001-09-12 | — | — | CN | disclosed |
| WO-1999040161-A1 | CHEMILUMINESCENT REACTIONS USING DIHYDROXYAROMATIC COMPOUNDS AND HETEROCYCLIC ENOL PHOSPHATES | LUMIGEN, INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| EP-0819119-A4 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN INC (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5840963-A | HALOGEN-SUBSTITUTED HYDROQUINONES HAVING ONE HYDROXY GROUP PROTECTED BY PHOSPHATE GROUP | LUMIGEN, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| US-5772926-A | ANALYSIS OF HYDROLYTIC ENZYMES AND ENZYME INHIBITORS; LABELED BINDING PAIRS | LUMIGEN, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| CN-1180349-A | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | LUMIGEN INC (US) | 1998-04-29 | — | — | CN | disclosed |
| EP-0819119-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1998-01-21 | — | — | EP | disclosed |
| WO-1997026245-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1997-07-24 | — | — | WO | disclosed |
| EP-0755457-A4 | NOVEL ARYL-N-ALKYLACRIDANTHIOCARBOXYLATE DERIVATIVES USEFUL FOR CHEMILUMINESCENT DETECTION | LUMIGEN INC (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0755457-A1 | NOVEL ARYL-N-ALKYLACRIDANTHIOCARBOXYLATE DERIVATIVES USEFUL FOR CHEMILUMINESCENT DETECTION | LUMIGEN, INC. (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1995028495-A1 | NOVEL ARYL-N-ALKYLACRIDANTHIOCARBOXYLATE DERIVATIVES USEFUL FOR CHEMILUMINESCENT DETECTION | LUMIGEN, INC. (US) | 1995-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030023089-A1 | Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes | PPP6C, PPP4C, PPP2CA | KDM4E 3418/4885ALDH1A1 2206/4885GLA 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.